Biogen Inc. drugs
7 results
Avonex (interferon beta-1a)
(interferon beta-1a)Biogen Inc.
Usage: AVONEX is indicated for treating relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Byooviz (ranibizumab-nuna)
(ranibizumab-nuna)BIOGEN INC.
Usage: BYOOVIZ is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV).
Plegridy (peginterferon beta-1a)
(peginterferon beta-1a)Biogen Inc.
Usage: PLEGRIDY is indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Qalsody (tofersen)
(tofersen)Biogen Inc.
Usage: QALSODY is indicated for treating amyotrophic lateral sclerosis (ALS) in adults with a superoxide dismutase 1 (SOD1) gene mutation. Its approval is based on reduced plasma neurofilament light chain (NfL) levels, with ongoing approval dependent on further confirmation of clinical benefit.
Tecfidera (dimethyl fumarate)
(dimethyl fumarate)Biogen Inc.
Usage: TECFIDERA is indicated for treating relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Tysabri (natalizumab)
(natalizumab)Biogen Inc.
Usage: TYSABRI is indicated for monotherapy in adults with relapsing forms of multiple sclerosis, including clinically isolated syndrome and active secondary progressive disease. It is also indicated for inducing and maintaining clinical response in adults with moderately to severely active Crohn's disease unresponsive to conventional treatments.
Vumerity (diroximel fumarate)
(diroximel fumarate)Biogen Inc.
Usage: VUMERITY is indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.